CN103073483B - 一种甲哌卡因及其光学对映体的制备方法 - Google Patents
一种甲哌卡因及其光学对映体的制备方法 Download PDFInfo
- Publication number
- CN103073483B CN103073483B CN201310030496.2A CN201310030496A CN103073483B CN 103073483 B CN103073483 B CN 103073483B CN 201310030496 A CN201310030496 A CN 201310030496A CN 103073483 B CN103073483 B CN 103073483B
- Authority
- CN
- China
- Prior art keywords
- mepivacaine
- add
- dimethylphenyl
- reaction
- formic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229960002409 mepivacaine Drugs 0.000 title claims abstract description 33
- INWLQCZOYSRPNW-UHFFFAOYSA-N mepivacaine Chemical compound CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C INWLQCZOYSRPNW-UHFFFAOYSA-N 0.000 title claims abstract description 23
- 230000003287 optical effect Effects 0.000 title claims abstract description 11
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- 238000006243 chemical reaction Methods 0.000 claims abstract description 28
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims abstract description 28
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims abstract description 24
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000019253 formic acid Nutrition 0.000 claims abstract description 14
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000004202 carbamide Substances 0.000 claims description 19
- 230000002829 reductive effect Effects 0.000 claims description 17
- 239000002904 solvent Substances 0.000 claims description 9
- 230000001035 methylating effect Effects 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- -1 react Chemical compound 0.000 claims description 3
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical group O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 11
- 238000003756 stirring Methods 0.000 abstract description 8
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 abstract description 3
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 abstract description 2
- SILRCGDPZGQJOQ-UHFFFAOYSA-N 2,6-Pipecoloxylidide Chemical compound CC1=CC=CC(C)=C1NC(=O)C1NCCCC1 SILRCGDPZGQJOQ-UHFFFAOYSA-N 0.000 abstract 1
- 231100001261 hazardous Toxicity 0.000 abstract 1
- 230000011987 methylation Effects 0.000 abstract 1
- 238000007069 methylation reaction Methods 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 42
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 230000005251 gamma ray Effects 0.000 description 7
- 238000009413 insulation Methods 0.000 description 7
- 239000012074 organic phase Substances 0.000 description 7
- 235000014347 soups Nutrition 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- 229930040373 Paraformaldehyde Natural products 0.000 description 5
- 229920002866 paraformaldehyde Polymers 0.000 description 5
- 239000002253 acid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 0 C*C(C)C*CC=C[C@@](C)C#CN*([C@]1NCCCCC1)O Chemical compound C*C(C)C*CC=C[C@@](C)C#CN*([C@]1NCCCCC1)O 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- ZKMNUMMKYBVTFN-HNNXBMFYSA-N (S)-ropivacaine Chemical compound CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C ZKMNUMMKYBVTFN-HNNXBMFYSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- RETIMRUQNCDCQB-UHFFFAOYSA-N mepivacaine hydrochloride Chemical compound Cl.CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C RETIMRUQNCDCQB-UHFFFAOYSA-N 0.000 description 1
- 229960002660 mepivacaine hydrochloride Drugs 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229960001549 ropivacaine Drugs 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 229960001957 stomatological preparations Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Landscapes
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310030496.2A CN103073483B (zh) | 2013-01-28 | 2013-01-28 | 一种甲哌卡因及其光学对映体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310030496.2A CN103073483B (zh) | 2013-01-28 | 2013-01-28 | 一种甲哌卡因及其光学对映体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103073483A CN103073483A (zh) | 2013-05-01 |
CN103073483B true CN103073483B (zh) | 2014-06-25 |
Family
ID=48150204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310030496.2A Active CN103073483B (zh) | 2013-01-28 | 2013-01-28 | 一种甲哌卡因及其光学对映体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103073483B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106117118A (zh) * | 2016-07-11 | 2016-11-16 | 江苏天和制药有限公司 | 一种盐酸布比卡因的制备工艺 |
CN113717094B (zh) * | 2021-08-11 | 2023-05-05 | 山东辰龙药业有限公司 | 一种制备甲哌卡因的方法 |
CN114591221A (zh) * | 2022-03-08 | 2022-06-07 | 广州曼翔医药有限公司 | 一种高纯度盐酸甲哌卡因的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB941748A (en) * | 1960-04-29 | 1963-11-13 | Res Lab Dr C Janssen Nv | Derivatives of 3-methyl-4-alkoxycarbonyl-4-phenylpiperidine |
US3810986A (en) * | 1971-12-06 | 1974-05-14 | Bofors Ab | Novel method and composition |
CN88101131A (zh) * | 1987-03-05 | 1988-09-14 | Bf谷德里奇公司 | N-(取代环状亚烷基亚氨基)-x-(3,5-二烷基-4-羟基苯基)-x′,x″-二烷基乙酰胺 |
-
2013
- 2013-01-28 CN CN201310030496.2A patent/CN103073483B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB941748A (en) * | 1960-04-29 | 1963-11-13 | Res Lab Dr C Janssen Nv | Derivatives of 3-methyl-4-alkoxycarbonyl-4-phenylpiperidine |
US3810986A (en) * | 1971-12-06 | 1974-05-14 | Bofors Ab | Novel method and composition |
CN88101131A (zh) * | 1987-03-05 | 1988-09-14 | Bf谷德里奇公司 | N-(取代环状亚烷基亚氨基)-x-(3,5-二烷基-4-羟基苯基)-x′,x″-二烷基乙酰胺 |
Non-Patent Citations (3)
Title |
---|
倪沛洲 * |
周萍 * |
王礼琛.Leuckart-Wallach反应初探.《药学进展》.2002,第26卷(第5期),279-281页. * |
Also Published As
Publication number | Publication date |
---|---|
CN103073483A (zh) | 2013-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2610776A1 (en) | Process for production of mono-substituted alkylated compound using aldimine or derivative thereof | |
JP6420294B2 (ja) | イリジウム(iii)錯体 | |
CN103073483B (zh) | 一种甲哌卡因及其光学对映体的制备方法 | |
CN103073484B (zh) | 一种甲哌卡因及其光学对映体的制备方法 | |
CN103172479B (zh) | 一种钯催化的联芳烃制备方法 | |
CN107673978B (zh) | 一种2,2-二氟环烷基甲胺的中间体及其制备方法 | |
AU2007213270A1 (en) | Improved process for producing nitroisourea derivatives | |
CN110981720B (zh) | 一种二芳基乙酸酯类化合物及制备方法 | |
CN103588600A (zh) | 一种空气氛围中铜催化有机硼酸化合物脱除硼酸基的方法 | |
JP2011528693A (ja) | 置換4−アミノ−ピリミジンの新規合成 | |
ES2392998A1 (es) | Procedimiento para la reducción catalítica de compuestos nitroaromáticos. | |
CN103936662B (zh) | 1-r1-3,3-二氟-4-r2-哌啶及其衍生物的制备方法 | |
JP2011057619A (ja) | 光学活性アミン化合物の製造方法、並びに、ジアステレオマー塩及びその製造方法 | |
CN103755701A (zh) | 一种具有光学活性的吡喹胺盐及其相应的吡喹胺的制备方法 | |
JP2008024596A (ja) | 光学活性2,6−ビスアミノメチルピリジン誘導体とその製造方法およびその使用 | |
JP5099932B2 (ja) | フルオレノンイミンを用いた炭素−炭素結合生成反応 | |
Liu et al. | One-pot multicomponent synthesis of highly functionalised piperidines from aromatic aldehydes, cyanoacetates, nitromethane and ammonium acetate | |
CN109232315B (zh) | 用于合成吡啶类化合物的中间体及其合成方法 | |
JP2017206485A (ja) | 光学活性な1,3−ジアミン誘導体およびその製造方法 | |
RU2311412C1 (ru) | Способ получения 1,3-ди[4-(6-метил-4-пиримидинон-2-тио)метилфенил]адамантана | |
RU2414452C1 (ru) | Способ одновременного получения 2-нитро-5-хлоранилина и 2-нитро-4-хлоранилина | |
CN104356057A (zh) | 一种3-氨基-4-甲基吡啶的制备方法 | |
US9573894B1 (en) | Energetic N-substituted 3, 3-dinitroazetidine plasticizer and preparation method thereof | |
Heravi et al. | DABCO–POCl3, A mild dehydrating agent for the preparation of nitriles from aldoximes | |
CN103524281B (zh) | 一种铜(ii)复合氯化剂及基于铜(ii)复合氯化剂合成1-氯-2-芳基乙炔的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANDONG MATTEL PHARM. CO., LTD. Free format text: FORMER OWNER: CHENGCHUANG MEDICINE TECH. DEVELOPMENT CO., LTD., SHANDONG Effective date: 20141028 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20141028 Address after: 250101 C410 room, overseas student Pioneer Park, No. 69 Huayang Road, Shandong, Ji'nan Patentee after: Shandong MATTEL Pharmaceutical Co., Ltd. Address before: 250101, Shandong, Ji'nan Province Road 2350 (Shandong Chong Chong Medical Technology Development Co., Ltd.) Patentee before: Shandong Chengchuang Medical Technology Development Co., Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of mepivacaine and optical enantiomer of mepivacaine Effective date of registration: 20150106 Granted publication date: 20140625 Pledgee: Qilu bank, Limited by Share Ltd, Ji'nan Jiefang East Road subbranch Pledgor: Shandong MATTEL Pharmaceutical Co., Ltd. Registration number: 2015370000001 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190509 Granted publication date: 20140625 Pledgee: Qilu bank, Limited by Share Ltd, Ji'nan Jiefang East Road subbranch Pledgor: Shandong MATTEL Pharmaceutical Co., Ltd. Registration number: 2015370000001 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of mepivacaine and optical enantiomer of mepivacaine Effective date of registration: 20190524 Granted publication date: 20140625 Pledgee: Shandong science and technology finance Company limited by guarantee Pledgor: Shandong MATTEL Pharmaceutical Co., Ltd. Registration number: 2019370000111 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201208 Granted publication date: 20140625 Pledgee: Shandong science and technology finance Company limited by guarantee Pledgor: SHANDONG MEITAI PHARM Co.,Ltd. Registration number: 2019370000111 |